Tech Stocks Lift Indices to Fresh Highs as Broader Market Struggles Following Inflation Report Jim Cramer Its Not Too Late to Buy Nvidia Own It Dont Trade It Omada Health OMDA Stock Today Rallies 087 Resistance at 1757 20260515 Iran Conflict Poised to Reshape Global Energy Markets Oil Executives Warn Experian SoFi Technologies Among Financial Services Firms in Market Roundup Perpetua Resources Secures 29 Billion Loan from US ExportImport Bank Financial Times Bond Markets Remain Too Complex for Many Investors With Five Key Pitfalls to Avoid Bain CapitalBacked Dhoot Transmission Files Updated DRHP for 1400 Crore IPO Indian Billionaires Accelerate Overseas Acquisitions Amid Domestic Growth Slowdown Fed Rate Hike Odds Rising on Prediction Markets for July 2027 ABR Q1 2026 Earnings Earnings Miss Exposes Headwinds as REIT Navigates Elevated Interest Rates Comstock Inc LODE Q1 2026 Earnings EPS Surpasses Estimates Despite Lack of Revenue ROST Q1 2026 Earnings Strong EPS Beat Drives Stock Rally TBH Q4 2025 Earnings Massive EPS Miss Sends Shares Lower Ellington Credit Company Q1 2026 Earnings EPS Miss Amidst Mixed Credit Markets LEXX Q1 2026 Earnings Narrowerthanexpected loss drives positive market reaction Murano Global Investments MRNO Nears Key Support After 5 Slide Odyssey Marine Exploration OMEX Edges Higher as Price Action Stabilizes Near Support Independence Realty Trust IRT Slips 130 as Apartment REIT Faces Sector Pressure Airgain AIRG Edges Higher Near Support Eyes Resistance at 740 NVX Surges 11 NOVONIX Limited Tests Resistance at 075 Rafael Holdings RFL Sees Modest Uptick Testing Key Resistance at 141 BrainsWay BWAY Slides 2 as Stock Nears Critical Support Zone Brightstar Lottery BRSL Holds Steady Assessing the Current Support and Resistance Structure AMN Healthcare Holds Steady Near Support as Sector Awaits Catalyst First Mid Bancshares Edges Lower Testing Support at 4386 China Confirms Order for 200 Boeing Jets Highlighting Aviation as Key Area for US Cooperation Stratasys SSYS Q1 2026 Earnings EPS Beats Estimates Despite Opaque Revenue Picture Enliven Therapeutics ELVN Pulls Back 263 as Resistance Holds Support Levels in Focus